SARS-CoV-2 Vaccination in Children and Adolescents—A Joint Statement of the European Academy of Paediatrics and the European Confederation for Primary Care Paediatricians

Łukasz Dembiński, Miguel Vieira Martins, Gottfried Huss, Zachi Grossman, Shimon Barak, Christine Magendie, Stefano del Torso, Hans Jürgen Dornbusch, Artur Mazur, Katarzyna Albrecht, Adamos Hadjipanayis

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Stopping the COVID-19 pandemic and its socio-economic consequences is only possible with a multifaceted strategy, including mass vaccination. Studies have been conducted mainly in adults, and data on the pediatric population is relatively limited. However, it appears that vaccination in children and adolescents is highly effective and safe. Despite the apparent benefits of vaccinating this age group, there are some medical and ethical concerns. Based on the above considerations, the European Academy of Paediatrics (EAP) and the European Confederation of Primary Care Pediatricians (ECPCP) assessed the current situation and presented recommendations for international and national authorities, pediatricians, and pediatric societies regarding vaccination against SARS-CoV-2 in children and adolescents.

Original languageEnglish
Article number721257
JournalFrontiers in Pediatrics
Volume9
DOIs
StatePublished - 23 Aug 2021

Keywords

  • COVID-19
  • adolescents
  • children
  • infectious diseases prevention
  • pandemic
  • vaccines

Fingerprint

Dive into the research topics of 'SARS-CoV-2 Vaccination in Children and Adolescents—A Joint Statement of the European Academy of Paediatrics and the European Confederation for Primary Care Paediatricians'. Together they form a unique fingerprint.

Cite this